BioSpace News Archive

Bicara Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference.

Taysha Gene Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference.

Singular Genomics Systems, Inc. announced the company is collaborating with the Broad Institute of MIT and Harvard to connect the Singular Genomics G4 sequencer to Terra, a data platform co-developed by the Broad Institute, Microsoft and Verily that connects researchers to each other and to the datasets and tools they need to achieve scientific breakthroughs.

ProMIS Neurosciences, Inc. announced its participation in the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10–13, 2022.

Avalo Therapeutics, Inc. today provides a comprehensive update on the Company’s growth opportunities and mid-stage development portfolio.

Alterity Therapeutics today announced the United States Patent and Trademark Office (USPTO) has granted a new patent (No. 11,155,547) to Alterity.

The RD Fund announces its participation in $115 million syndicated Series B round for SalioGen Therapeutics to support the company’s preclinical research into novel genetic medicines for inherited retinal disorders.

Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022.

Gennao Bio today announced the appointments of Joseph W. McIntosh, M.D., as chief medical officer, and Anuj Goswami, J.D., MBA, as general counsel.

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, provided an update today from the ongoing Phase 1 clinical trial of INB-200, an autologous DeltEx drug resistant immunotherapy (DRI).